Hypha Labs Inc (FUNI)

[mijReswoh]

Post #578 is key. Ideal Joint Venture deal. Exactly the deal us investors and DIGI needs. It means delusion will be limited compared to most of these penny stocks.These labs are going to be cash cows. There lab in Nevada is kicking ass, revenue will keep going up, profitability is just around the corner.Nice place to have a base, Viva Las Vegas. This is the type of investment that ya Put a nice chunk into and hope it goes down for awhile so ya can get some more $ in before it takes off. The nice thing is that ya dont have to worry about it going down too much cuz it's not going to. Already an extremely low Market cap. Dont see the market cap being able the to go down much from its already low level.Downside is limited, upside is unlimited.

[Fivespeedchatter]

Already did in Cali buddy.... Mobile lab... Southern Cali association with CAT TECH...read some 8ks and catch up on the TANGIBLE GROWTH...

[brandao]

So they only have one lab in Nevada ? Are there other labs opening in other states or what? ... their SS is wayyyyy better than signal bay but signal bay seems like they set up shop in Oregon and about to in cali

[Fallingknife75]

There is a voice from the past :) Hope all is well.

DIGP has good fundamentals and are positioning themselves nicely. If they keep expenses under control they can be profitable soon with even moderate revenue growth. The low share count means the stock will run quickly once others catch on. I am buying small chunks of shares on any pullbacks and just sitting on them, a little patience will pay off well here.

All the best,

Knife

[mijReswoh]

Major growth coming very soon. I'm hoping the partnership deal they announced starts to make waves. It's coming soon. This stock is going to catch fire eventually. Nice revenues here. Low risk. Only 6 million cap. Huge huge upside coming. Low risk. Park your money here and be patient for the pay off. 10 bagger coming. Not a day traders stock at this time. Take some money and let it sit.

[StevenRisk]

We meet again.This is my other testing lab here. I believe they will have an excellent Q coming as they are well positioned with Nevada. Also other acquisitions will be closing any day IMO.

[Fallingknife75]

Fundamentals are solid, share count although growing is very low for the industry, high gross margins and good revenue growth will lead to bottom line profitability possibly this year IMO.

I am slowly building a position in DIGP while no one else cares about it and the price is dropping. With the small share structure here it will move quickly when the herd catches on. I am in no hurry, thinking longer term; I don't generally make price projections however your 10 bagger call is certainly possible.

All the best,

Knife

[mijReswoh]

Put on the radar. growing revenues. Super low market cap. Big time expansion soon. More government regulation coming and this will explode. Will be a 10 bagger.

[barknbud]

Looks like an insider give away---Conver PR at 20cents---and then there are the recent shares to Peterson and Axtmayer---the story is great but chances are you can buy it lower!

[General Grievous]

As of the last filing yes..

[WallStreetSTTA]

Is this SS right? or needs updating?..https://www.otcmarkets.com/stock/DIGP/profile

[Fibanotch]

interesting

[MTpennystocks]

February 28, 2017 - 9:00 AM EST
Print

Email Article

Font Down

Font Up

Charts
DIGP 0,28 0,00
Auj. 5j 1m 3m 1a 5a 10a

Digipath Appoints Dr. Alfredo Axtmayer to Board of Directors

NEW YORK, Feb. 28, 2017 /PRNewswire/ -- Digipath, Inc. (OTCQB:DIGP), an independent cannabis lab testing and media firm, is pleased to announce that it has appointed Alfredo Axtmayer, M.D. to its Board of Directors.

Dr. Axtmayer is an orthopedic surgeon in Wallingford, Connecticut and is affiliated with multiple hospitals in the area, including Hospital of St. Raphael and MidState Medical Center. Dr. Axtmayer serves as an Associate Professor at the MidState Medical Center Campus Department of Surgery, as a Clinical Instructor in Orthopaedics and Rehabilitation at Yale University School of Medicine, and as an Assistant Clinical Professor in the Yale University School of Medicine's Department of Orthopaedics and Rehabilitation.

He has also authored instructional course lectures on the management and diagnosis of prosthetic joint infections, hip fractures, carpal tunnel syndrome, and medial knee osteoarthritis, and he has written academy guidelines on the management of knee osteoarthritis, low back pain, hip fractures, and rotator cuff disorders.

Dr. Axtmayer received his B.A. from Yale and his M.D. from Yale University School of Medicine.

Joseph Bianco, the CEO of Digipath, commented, "We are honored to add Dr. Alfredo Axtmayer to Digipath's Board of Directors. Dr. Axtmayer's work as a physician and as a Clinical Instructor and Assistant Clinical Professor at the Yale University School of Medicine will bring great expertise and insight to our company. It may also help us establish public-private partnerships with the university community and its constituents in an effort to further develop Digipath's science, data and other intellectual property."

[Cabbie_news]

https://g.co/kgs/tSo22M

[thehumanchessmachine]

how many labs does digipath has and where are they located? anybody ???

[MTpennystocks]

An exemple: more medical marijuana growers = more analysis by digipath. No worried at all

http://www.nydailynews.com/new-york/new-york-seeks-license-medical-marijuana-growers-article-1.2980722?cid=bitly

[MTpennystocks]

Digipath is currently on the medical side, so the current results will not be affected. Trump is 100% for the medical cannabis.

[MTpennystocks]

Digipath, Inc. Enters into Joint Venture Agreement with Strategic Investor

LAS VEGAS, Feb. 22, 2017 /PRNewswire/ — Digipath, Inc. (OTC: DIGP), an independent cannabis lab testing and media firm, is pleased to announce that it has entered into an agreement with a strategic investor, OC Testing LLC, to build additional cannabis testing labs. Pursuant to this agreement:

Digipath and the investor intend to open cannabis testing labs in jurisdictions outside of Nevada, with Digipath to provide turnkey services and its industry expertise and the OC Testing to provide all funding required to open such labs. Services to be provided by Digipath will include oversight of the purchase and installation of all laboratory equipment, responsibility for obtaining state and local regulatory approvals, and the identification and hiring of laboratory personnel.
OC Testing will be responsible for financing the building of each additional lab, including the provision of sufficient startup working capital.
Digipath will be entitled to 20% of the cash flow generated by each such lab. In addition, Digipath will be reimbursed for its expenses during the construction phase of each testing Lab, and once a lab begins operations, Digipath will be entitled to a monthly fee of 3.5% of gross revenues until OC Testing has received distributions equal to its invested capital. Thereafter, Digipath will be entitled to a monthly fee equal to 7% of gross revenues for so long as it remains an owner of each such lab.
All new labs will be branded under the “Digipath Labs” name, and will meet all the standards of quality and professionalism set by the Digipath Labs flagship operation in Nevada, which operates under the most demanding regulations in the nation.
The parties intend to first launch a medical marijuana testing lab in the State of California, followed by additional labs in Florida and other States. However, nothing in the agreement prevents Digipath from establishing or purchasing its own labs

This agreement is an important step in expanding the Digipath Labs brand in the cannabis lab testing market and provides us with a strategic and financial partner as we scale into other legal cannabis markets. We believe that this model will enable us to better protect and enhance the industry-leading benchmarks we have set by ensuring our direct control over each operation.

Todd Denkin DigipathTodd Denkin, COO of Digipath

A spokesperson for OC Testing, LLC, stated, “We believe that lab testing services in the cannabis markets are crucial to ensuring patient safety and consumer confidence. After an extended search for the best partner, it is clear that Digipath is setting the industry standard for compliance, data driven standards and best practices.”

About Digipath, Inc.

Digipath Inc. is a cannabis testing and media firm that supports the cannabis industry’s best practices for reliable testing and delivers cannabis news coverage and education about the cannabis industry. Digipath’s two business units are Digipath Labs™ and TNM News Corp. Digipath Labs™ is working to set the industry standard for testing all forms of cannabis-based products using FDA-compliant laboratory equipment and proprietary standard operating procedures (SOP) to ensure product safety and efficacy. TNM News Corp has pioneered a cannabis-focused news network, The National Marijuana News™, which delivers news, interviews, and education on all things cannabis.

For more information please visit http://www.Digipath.com and www.DigipathLabs.com.

Original press release: http://www.prnewswire.com/news-releases/digipath-inc-enters-into-joint-venture-agreement-with-strategic-investor-300411653.html

Before this cannabis stock news is here, it's published to subscribers on 420 Investor.

[Ronin]

MJ is a federal offense and there is plenty of talk of enforcing it on the state level...

http://www.usatoday.com/story/news/2016/08/11/dea-marijuana-remains-illegal-under-federal-law/88550804/

be careful! Not as much revenue here as one might think...

[Magnum7419]

Good luck to all that held on.........
Who is OC Testing LLC ?

"Digipath will be entitled to 20% of the cash flow generated by each such lab. In addition, Digipath will be reimbursed for its expenses during the construction phase of each testing Lab, and once a lab begins operations, Digipath will be entitled to a monthly fee of 3.5% of gross revenues until OC Testing has received distributions equal to its invested capital. Thereafter, Digipath will be entitled to a monthly fee equal to 7% of gross revenues for so long as it remains an owner of each such lab."


http://finance.yahoo.com/news/digipath-inc-enters-joint-venture-152000593.html

[oatsuzn]

yeah this definitely broke out today. Wasn't expecting that PR today. Good PR not fluff.

[gr8investment]

DIGP CHART PRIMED FOR BLUE SKIES

[gr8investment]

LEGIT MMJ TESTING FACILITIES DIGP!

[gr8investment]

HIDDEN GEM IN DIGP! TIME TO POUNCE!

[gr8investment]

DIGP GOING INTO BREAKOUT MODE

[StevenRisk]

Record volume today.Looks like we could be going much higher. They are going to build labs unlike the competitor who is acquiring them. In for 10k.

[Parttimetrader]

Came upon this from AB hope the link works

https://marketfy.com/portal/420investor/

[MTpennystocks]

http://lasvegas.carpediem.cd/events/2635271-meet-the-professional-ask-the-lab-at-oasis-medical/

[MTpennystocks]

[aceling]

10q looks good. Improvement from the previous.

[britto106]

They registered the com and .net domain extensions 2 days earlier also.

[MTpennystocks]

Digipath lab in california? look at the registrant

http://wa-com.com/digipathlabscalifornia.info

[britto106]

I disagree. I don't think you understand their plan. They are buying testing companies who don't currently offer MJ testing and they will add it to them. This makes sense to me for a couple reasons:
1) they can value the company they are buying based on current financials unlike purchasing an existing MJ lab where you now have to pay a huge premium based on the perceived value they now have from the changes in the laws.
2) These existing businesses should be able to stand on their own from day 1 from their existing business and the MJ business will be on top of that.

[a surfer]

Looks primed for lift off.

[MTpennystocks]

[oatsuzn]

PZOO is a straight up scam. I would suggest against it unless for ATM purposes.

SGBY(Signal Bay) is the best publicly offered cannabis testing investment in the industry. If you haven't done so yet, check them out.

I recently sold my DIGP position when it broke and held over .23 finally. I held DIGP for a few months and was hoping it'd be my longterm NV position for cannabis testing but branching out to NJ and PA just doesn't make sense to me. It doesn't strengthen their cannabis testing brand. As states legalize cannabis, they will all mandate testing. Not sure why they're straying away from that.

[JTHawk]

Their issue is they are broke and bureaucracy is slow. Until States get the industry moving, revenue will lag. Also, they are making a huge mistake for in their attempt to expand their footprint in other states. Though great idea in theory, the revenue in those states won't pay for the overhead and they'll drive themselves deeper into debt. This is not just them, the bureaucracy is causing most of the sector and/or labs to bleed cash. Be patient. Whichever labs survive, will flourish! I say DIGP and PZOO have the best odds.

[Goodbuddy4863]

Thanks Magnum

I was just doing some D/D.

Later....

[Magnum7419]

Sorry if I misled anyone.....I have soldout of DIGP yesterday and went all in with "S". There is nothing wrong with DIGP but I feel "S" is a better play.....

[Goodbuddy4863]

You really believe this Stock will got to $100 Bucks per share in mid 2017.

Rumor I find hard to believe.

It would be nice if it was actually true.

Just saying.

Good Luck Magnum... in all Your Investments.

[oatsuzn]

Digipath Enters into Letter of Intent to Acquire Clinical Lab Companies

http://app.quotemedia.com/quotetools/newsStoryPopup.go?storyId=6142096714624501&topic=DIGP&symbology=null&cp=null&webmasterId=102144

LOI to acquire a lab in NJ and a lab in PA(both are non MJ related). Growth is good but neither labs are in established or burgeoning MJ markets. Wonder what they're paying for these?

[StevenRisk]

Only positive I saw with the 10k was a 10% increase in revenues from Q3 to Q4. Also a $600k reduction in total losses. The financials still suck pretty bad. Another positive is Nevada legalization.

[StevenRisk]

Yeah but nothing new...still waiting.

[GreenScarab]

DIGP on cover of new issue of Cannainvestor

Represented as a bull along with a feature article.

Link here downloads issue

[jjr04001]

$DIGP let's get this started

[Magnum7419]

No, they were very general in their statements. I need to listen to the call one more time as T.Denkins did make some early comments that are worth a review but overall it was Fluff IMHO.

[StevenRisk]

Did they say where the potential acquisitions were? Basically asking if it is within Ca. or they did not say. This new guy that is the president does have a history with merger and acquisitions which is good IMO.

[Magnum7419]

CC just ended and there was no specifics given other than they have identified app 6 acquisition targets and those targeted apparently have assets and or good cash flow that has impressed some financial institutions which will make Nasdaq listing easier to accomplish in the near term.............IMHO

copy of the CC will be available in about a week.

[Magnum7419]

CCall is about to begin........ good luck to all long shareholders

[Magnum7419]

Digp offers 48 hr turnaround !!!!!!


https://www.facebook.com/digipathlabsnv/photos/a.386710588156240.1073741827.381277092032923/653212261506070/?type=1&theater